Inhibitors of serine proteases, particularly HCV NS3-NS4A...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S410000, C514S019300, C548S424000, C548S429000, C548S430000

Reexamination Certificate

active

10280940

ABSTRACT:
The present invention relates to peptidomimetic compounds that inhibit serine protease activity, particularly the activity of hepatitis C virus NS3–NS4A protease. As such, they act by interfering with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The invention further relates to compositions comprising these compounds either for ex vivo use or for administration to a patient suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a patient by administering a composition comprising a compound of this invention.

REFERENCES:
patent: WO 97/43310 (1997-11-01), None
patent: WO 98/17679 (1998-04-01), None
patent: WO 98/46630 (1998-10-01), None
patent: WO 99/07733 (1999-02-01), None
patent: WO 99/07734 (1999-02-01), None
patent: WO 99/50230 (1999-10-01), None
patent: WO 99/64442 (1999-12-01), None
patent: WO 00/09543 (2000-02-01), None
patent: WO 00/09558 (2000-02-01), None
patent: 01/74768 (2001-10-01), None
patent: 02/08244 (2002-01-01), None
LaPlante, S.R., et al., “NMR Line-Broadening and Transferred NOESY as a Medicinal Chemistry Tool for Studying Inhibitors of the Hepatits C Virus NS3 Protease Domain,”Bioorgan.&Med. Chem. Ltrs,10:2271-2274 (2000).
Llinás-Brunet, M., et al., “Highly Potent and Selective Peptide-Based Inhibitors of the Hepatitis C Virus Serine Protease: Towards Smaller Inhibitors,”Bioorgan.&Med. Chem Ltrs.,10:2267-2270 (2000).
Dunsdon, R. M., et al., “Solid Phase Synthesis of Aminoboronic Acids: Potent Inhibitors of the Hepatitis C Virus NS3 Proteinase,”Bioorg.&Med. Chem. Ltrs.,10:1577-1579 (2000).
Han, W., et al., “α-Ketoesters and α-Diketones as HCV NS3 Protease Inhibitors,”Bioorgan.&Med. Chem. Ltrs.,10:711-713 (2000).
Llinás-Brunet, M., et al., “Peptide-Based Inhibitors of the Hepatitis C Virus Serine Protease,”Bioorgan.&Med. Chem. Ltrs.,8:1713-1718 (1998).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inhibitors of serine proteases, particularly HCV NS3-NS4A... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of serine proteases, particularly HCV NS3-NS4A..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of serine proteases, particularly HCV NS3-NS4A... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3736967

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.